Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

Breast Cancer Research and Treatment

Volumn 106, Issue 1, 2007, Pages 121-126

  Ye, Chuanzhong ^a   Dai, Qi ^a   Lu, Wei ^c   Cai, Qiuyin ^a   Zheng, Ying ^c   Shu, Xiao Ou ^a   Gu, Kai ^c   Gao, Yu Tang ^b   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c Shanghai Center for Disease Control and Prevention   (China)

Author keywords

ATM; Breast cancer; Molecular epidemiology; Polymorphism; Risk

Indexed keywords

ATM PROTEIN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

EID: 34848890362     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9473-8     Document Type: Article

References (21)

1. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N (2005) ATM signaling and genomic stability in response to DNA damage. Mutat Res 569:123-132
2. Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D (2005) Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:821-825
3. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, nton-Culver H, Boice JD, Rosenstein BS, Borresen-Dale AL, Gatti RA, Concannon P, Haile RW (2003) ATM variants 7271T > G and IVS10-6T > G among women with unilateral and bilateralbreast cancer. Br J Cancer 89:1513-1516
4. Bretsky P, Haiman CA, Gilad S, Yahalom J, Grossman A, Paglin S, van Den BD, Kolonel LN, Skaliter R, Henderson BE (2003) The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 12:733-738
5. Hall J (2005) The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Lett 227:105-114
6. Szabo CI, Schutte M, Broeks A, Houwing-Duistermaat JJ, Thorstenson YR, Durocher F, Oldenburg RA, Wasielewski M, Odefrey F, Thompson D, Floore AN, Kraan J, Klijn JG, van den Ouweland AM, Wagner TM, Devilee P, Simard J, van't Veer LJ, Goldgar DE, Meijers-Heijboer H (2004) Are ATM mutations 7271T - >G and IVS10-6T - >G really high-risk breast cancer-susceptibility alleles? Cancer Res 64:840-3
7. Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 63:3325-3333
8. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES (2001) Linkage disequilibrium in the human genome. Nature 411:199-204
9. Pritchard JK, Przeworski M (2001) Linkage disequilibrium in humans: models and data. Am J Hum Genet 69:1-14
10. Hirschhorn JN, Daly MJ (2005). Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108
11. Tamimi RM, Hankinson SE, Spiegelman D, Kraft P, Colditz GA, Hunter DJ (2004) Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res 6:R416-R422
12. Koren M, Kimmel G, Ben-Asher E, Gal I, Papa MZ, Beckmann JS, Lancet D, Shamir R, Friedman E (2006) ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 94:1537-1543
13. Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomaki K, Blomqvist C, Borresen-Dale AL, Nevanlinna H (2006) ATM variants and cancer risk in breast cancer patients from Southern Finland. BMC Cancer 6:209
14. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Nieminen P, Winqvist R (2005) Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer 116:69-72
15. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717-8725
16. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, Sellers TA, Kushi LH, Ruan Z, Bostick RM, Jin F, Zheng W (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295-300
17. Shu XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, Hebert JR, Ruan Z, Gao YT, Zheng W (2001) Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94:449-455
18. Buchholz TA, Weil MM, Ashorn CL, Strom EA, Sigurdson A, Bondy M, Chakraborty R, Cox JD, McNeese MD, Story MD (2004) A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. Cancer 100:1345-1351
19. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169
20. Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Bruning T, Brauch H (2004) ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13:2059-2064
21. Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 92:1151-1158